Peptide Reference Desk
SYN-AKE vs Argireline: what “expression-line peptide” leaves out
SYN-AKE and Argireline are marketed for similar cosmetic concerns, but their ingredient identities, sequences and evidence files remain distinct.
A marketing category, not a molecule class
SYN-AKE is associated with a synthetic tripeptide ingredient commonly listed as Dipeptide Diaminobutyroyl Benzylamide Diacetate. Argireline is associated with Acetyl Hexapeptide-8. Both are sold through expression-line language, yet they are not structural variants of one peptide.
Three questions for the formula sheet
- What exact INCI name is present?
- Does the stated percentage refer to active peptide or supplier solution?
- Was the evidence generated on the raw material or the finished product?
Answers to those questions are more useful than a “needle-free” comparison, which imports a medical metaphor into cosmetic evidence.
Keep efficacy and identity separate
LC-MS or chromatography can support ingredient identity; it does not prove a visible cosmetic outcome. Conversely, a finished-product study cannot identify an undeclared raw material. The archive should keep both files and avoid filling gaps with brand copy.
Verify with primary records
Use the primary paper, current regulator label or lot-linked analytical file for the claim it supports. A search result is a route to evidence, not the evidence itself.